Top News
CT-P55: How Celltrion’s New Biosimilar Approval Will Transform Clinical Trials in...
Celltrion receives EMA approval to reduce patient enrollment for CT-P55 trial, aiming to cut costs and duration of clinical development.
- Our Sponsors Ad -